Sanofi India Limited — Updates, 04-08-2026: General Updates
04-08-2026 | 08:31 pm
04-08-2026 | 08:31 pm
Sanofi India posted strong Q2 results: domestic sales rose 8%, with Profit Before Tax up 19% to ₹112.3 Cr. Growth was led by a 14% increase in the insulin portfolio and 70% acceleration in the public sector business. The CFO is stepping down.
No comments yet. Be the first to comment!
